Borch-JohnsenK, AndersenPK, DeckertT. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1985; 28:590–596.
2.
KrolewskiM, EggersPW, WarramJH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int, 1996; 50:2041–2046.
3.
PambiancoG, CostacouT, EllisD, BeckerDJ, KleinR, OrchardTJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes, 2006; 55:1463–1469.
4.
HovindP, TarnowL, RossingK, RossingP, EisingS, LarsenN, BinderC, ParvingHH. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care, 2003; 26:1258–1264.
5.
NordwallM, BojestigM, ArnqvistHJ, LudvigssonJ. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linkoping Diabetes Complications Study. Diabetologia, 2004; 47:1266–1272.
6.
FinneP, ReunanenA, StenmanS, GroopPH, Gronhagen-RiskaC. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA, 2005; 294:1782–1787.
7.
MaahsDM, RewersM. Mortality and renal disease in type 1 diabetes mellitus—progress made, more to be done. J Clin Endocrinol Metab, 2006; 91:3757–3759.
8.
American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care, 2010; 33,Suppl 1:S11–S61.
9.
RuleAD, LarsonTS, BergstralhEJ, SlezakJM, JacobsenSJ, CosioFG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med, 2004; 141:929–937.
10.
StevensLA, SchmidCH, GreeneT, ZhangYL, BeckGJ, FroissartM, HammLL, LewisJB, MauerM, NavisGJ, SteffesMW, EggersPW, CoreshJ, LeveyAS. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis, 2010; 56:486–495.
11.
LeveyAS, BoschJP, LewisJB, GreeneT, RogersN, RothD. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130:461–470.
12.
TanGD, LewisAV, JamesTJ, AltmannP, TaylorRP, LevyJC. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care, 2002; 25:2004–2009.
13.
PerkinsBA, NelsonRG, OstranderBE, BlouchKL, KrolewskiAS, MyersBD, WarramJH. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol, 2005; 16:1404–1412.
14.
BeauvieuxMC, LeMF, LasseurC, RaffaitinC, PerlemoineC, BartheN, ChauveauP, CombeC, GinH, RigalleauV. New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care, 2007; 30:1988–1994.
15.
RuleAD, BergstralhEJ, SlezakJM, BergertJ, LarsonTS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int, 2006; 69:399–405.
16.
StevensLA, CoreshJ, SchmidCH, FeldmanHI, FroissartM, KusekJ, RossertJ, Van LenteF, BruceRD3rd, ZhangYL, GreeneT, LeveyAS. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis, 2008; 51:395–406.
17.
MacIsaacRJ, TsalamandrisC, ThomasMC, PremaratneE, PanagiotopoulosS, SmithTJ, PoonA, JenkinsMA, RatnaikeSI, PowerDA, JerumsG. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia, 2006; 49:1686–1689.
18.
StevensLA, CoreshJ, GreeneT, LeveyAS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med, 2006; 354:2473–2483.
19.
PerkinsBA, FicocielloLH, SilvaKH, FinkelsteinDM, WarramJH, KrolewskiAS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med, 2003; 348:2285–2293.
20.
WalkerJD, CloseCF, JonesSL, RaffteryM, KeenH, VibertiG, OsterbyR. Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int, 1992; 41:741–748.
21.
DCCT/EDIC Research Group. de BoerIH, SunW, ClearyPA, LachinJM, MolitchME, SteffesMW, ZinmanB. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med, 2011; 365:2366–2376.
22.
PerkinsBA. Intensive therapy and GFR in type 1 diabetes. N Engl J Med, 2012; 366:856–858.
23.
MauerM, DrummondK. The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes, 2002; 51:1572–1579.
24.
PezzolesiMG, PoznikGD, MychaleckyjJC, PatersonAD, BaratiMT, KleinJB, NgDP, PlachaG, CananiLH, BochenskiJ, WaggottD, MerchantML, KrolewskiB, MireaL, WanicK, KatavetinP, KureM, WolkowP, DunnJS, SmilesA, WalkerWH, BorightAP, BullSB. DCCT/EDIC Research Group. DoriaA, RogusJJ, RichSS. DCCT/EDIC Research Group. WarramJH, KrolewskiAS. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes, 2009; 58:1403–1410.
25.
MageeGM, BilousRW, CardwellCR, HunterSJ, KeeF, FogartyDG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia, 2009; 52:691–697.
26.
MogensenCE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest, 1986; 46:201–206.
27.
LervangHH, JensenS, Brochner-MortensenJ, DitzelJ. Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1988; 31:723–729.
28.
LervangHH, JensenS, Brochner-MortensenJ, DitzelJ. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?Diabet Med, 1992; 9:635–640.
29.
ChiarelliF, VerrottiA, MorgeseG. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol, 1995; 9:154–158.
30.
YipJW, JonesSL, WisemanMJ, HillC, VibertiG. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes, 1996; 45:1729–1733.
31.
CaramoriML, GrossJL, PecisM, de AzevedoMJ. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care, 1999; 22:1512–1516.
32.
DahlquistG, StattinEL, RudbergS. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant, 2001; 16:1382–1386.
33.
AminR, TurnerC, van AkenS, BahuTK, WattsA, LindsellDR, DaltonRN, DungerDB. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study. Kidney Int, 2005; 68:1740–1749.
34.
SteinkeJM, SinaikoAR, KramerMS, SuissaS, ChaversBM, MauerM. The early natural history of nephropathy in Type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes, 2005; 54:2164–2171.
35.
ZerbiniG, BonfantiR, MeschiF, BognettiE, PaesanoPL, GianolliL, QuerquesM, MaestroniA, CaloriG, Del MaschioA, FazioF, LuziL, ChiumelloG. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes, 2006; 55:2620–2625.
36.
ThomasMC, MoranJL, HarjutsaloV, ThornL, WadénJ, SaraheimoM, TolonenN, LeiviskäJ, JulaA, ForsblomC, GroopPH. the FinnDiane Study Group: Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?Diabetologia, 2012; 55:1505–1513.
37.
JerumsG, PremaratneE, PanagiotopoulosS, MacIsaacRJ. The clinical significance of hyperfiltration in diabetes. Diabetologia, 2010; 53:2093–2104.
38.
SchwartzGJ, WorkDF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol, 2009; 4:1832–1843.
39.
MaahsDM, JalalD, McFannK, RewersM, Snell-BergeonJK. Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol, 2011; 6:1952–1955.
40.
MaahsDM, PrenticeN, McFannK, Snell-BergeonJK, JalalD, BishopFK, AragonB, WadwaRP. Age and sex influence cystatin C in adolescents with and without type 1 diabetes. Diabetes Care, 2011; 34:2360–2362.
41.
RetnakaranR, CullCA, ThorneKI, AdlerAI, HolmanRR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes, 2006; 55:1832–1839.
42.
PeraltaCA, ShlipakMG, JuddS, CushmanM, McClellanW, ZakaiNA, SaffordMM, ZhangX, MuntnerP, WarnockD. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA, 2011; 305:1545–1552.
43.
NinomiyaT, PerkovicV, de GalanBE, ZoungasS, PillaiA, JardineM, PatelA, CassA, NealB, PoulterN, MogensenCE, CooperM, MarreM, WilliamsB, HametP, ManciaG, WoodwardM, MacMahonS, ChalmersJ. ADVANCE Collaborative Group: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol, 2009; 20:1813–1821.
44.
CherneyDZ, SochettEB, DekkerMG, PerkinsBA. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med, 2010; 27:1358–1365.
45.
WisemanMJ, MangiliR, AlberettoM, KeenH, VibertiG. Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int, 1987; 31:1012–1018.
46.
DullaartRP, MeijerS, SluiterWJ, DoorenbosH. Renal haemodynamic changes in response to moderate hyperglycaemia in type 1 (insulin-dependent) diabetes mellitus. Eur J Clin Invest, 1990; 20:208–213.
47.
SkøttP, VaagA, Hother-NielsenO, AndersenP, BruunNE, GieseJ, Beck-NielsenH, ParvingHH. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest, 1991; 51:715–727.
48.
JonesSL, KontessisP, WisemanM, DoddsR, BognettiE, PintoJ, VibertiG. Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic patients. Kidney Int, 1992; 41:1620–1628.
49.
De CosmoS, EarleK, MorocuttiA, WalkerJ, RuggenentiP, RemuzziG, VibertiGC. Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion. Diabetologia, 1993; 36:622–627.
50.
American Diabetes Association:. Standards of medical care in diabetes—2012. Diabetes Care, 2012; 35,Suppl 1:S11–S63.
51.
MauerM, ZinmanB, GardinerR, SuissaS, SinaikoA, StrandT, DrummondK, DonnellyS, GoodyerP, GublerMC, KleinR. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med, 2009; 361:40–51.
52.
KnightEL, VerhaveJC, SpiegelmanD, HillegeHL, de ZeeuwD, CurhanGC, de JongPE. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int, 2004; 65:1416–1421.
53.
VergouweY, Soedamah-MuthuSS, ZgiborJ, ChaturvediN, ForsblomC, Snell-BergeonJK, MaahsDM, GroopPH, RewersM, OrchardTJ, FullerJH, MoonsKG. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia, 2010; 53:254–262.
